Elevance Health Files Routine 8-K on Jan 25, No Major News

TL;DR

**Elevance Health's 8-K is a standard administrative update, nothing to see here.**

AI Summary

Elevance Health, Inc. filed an 8-K on January 25, 2024, reporting an "Other Event" that occurred on January 23, 2024. This filing is a routine disclosure, primarily updating administrative details such as the company's current name, previous names (Anthem, Inc. and WELLPOINT, INC), and contact information. For investors, this filing indicates no significant operational or financial changes, suggesting business as usual for the healthcare giant.

Why It Matters

This filing is largely administrative, confirming basic company information and indicating no immediate material changes that would impact the stock's value or an investor's decision.

Risk Assessment

Risk Level: low — The filing contains no new material information that would introduce or alter investment risk.

Analyst Insight

A smart investor would recognize this as a routine administrative filing with no new material information, thus requiring no immediate action regarding their investment in ELV.

Key Numbers

• 001-16751 — Commission File Number (Identifies Elevance Health, Inc. with the SEC.)
• 35-2145715 — IRS Employer Identification No. (Identifies Elevance Health, Inc. for tax purposes.)

Key Players & Entities

• Elevance Health, Inc. (company) — the registrant filing the 8-K
• Anthem, Inc. (company) — a former name of Elevance Health, Inc.
• WELLPOINT, INC (company) — a former name of Elevance Health, Inc.
• January 25, 2024 (date) — the filing date of the 8-K
• January 23, 2024 (date) — the date of the earliest event reported in the 8-K
• 001-16751 (number) — the Commission File Number for Elevance Health, Inc.
• 35-2145715 (number) — the IRS Employer Identification No. for Elevance Health, Inc.
• Indiana (company) — State of incorporation for Elevance Health, Inc.
• 220 Virginia Ave Indianapolis , IN 46204 (company) — Address of principal executive offices for Elevance Health, Inc.
• 833-401-1577 (number) — Registrant’s telephone number for Elevance Health, Inc.

FAQ

From the Filing

0001193125-24-015557.txt : 20240125 0001193125-24-015557.hdr.sgml : 20240125 20240125172052 ACCESSION NUMBER: 0001193125-24-015557 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20240123 ITEM INFORMATION: Other Events FILED AS OF DATE: 20240125 DATE AS OF CHANGE: 20240125 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Elevance Health, Inc. CENTRAL INDEX KEY: 0001156039 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance IRS NUMBER: 352145715 STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-16751 FILM NUMBER: 24563253 BUSINESS ADDRESS: STREET 1: 220 VIRGINIA AVENUE CITY: INDIANAPOLIS STATE: IN ZIP: 46204 BUSINESS PHONE: 8003311476 MAIL ADDRESS: STREET 1: 220 VIRGINIA AVENUE CITY: INDIANAPOLIS STATE: IN ZIP: 46204 FORMER COMPANY: FORMER CONFORMED NAME: Anthem, Inc. DATE OF NAME CHANGE: 20141202 FORMER COMPANY: FORMER CONFORMED NAME: WELLPOINT, INC DATE OF NAME CHANGE: 20100105 FORMER COMPANY: FORMER CONFORMED NAME: WELLPOINT INC DATE OF NAME CHANGE: 20041130 8-K 1 d743645d8k.htm 8-K 8-K false 0001156039 0001156039 2024-01-23 2024-01-23     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K     CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 January 25, 2024 ( January 23, 2024 ) Date of Report (Date of earliest event reported)     Elevance Health, Inc. (Exact name of registrant as specified in its charter)       Indiana   001-16751   35-2145715 (State or other jurisdiction of incorporation or organization)   (Commission File Number)   (IRS Employer Identification No.) 220 Virginia Ave Indianapolis , IN 46204 (Address of principal executive offices and zip code) (833) 401-1577 (Registrant’s telephone number, including area code)     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:     ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)     ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)     ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))     ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol   Name of each exchange on which registered Common Stock, Par Value $0.01   ELV   New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined Rule 405 of the Securities Act (§230.405 of this chapter) or Rule 12b-2 of the Exchange Act (§240.12b-2 of this chapter). Emerging growth company   ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.       Item 8.01 – Other Events On January 23, 2024, the Audit Committee of the Board of Directors of Elevance Health, Inc. (the “Company”) declared a quarterly cash dividend to the Company’s shareholders of $1.63 per share. This quarterly dividend is payable on March 22, 2024 to shareholders of record as of March 8, 2024. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized on this 25 th day of January,